Here's Why Wanbangde Pharmaceutical Holding Group (SZSE:002082) Can Manage Its Debt Responsibly

Simply Wall StNov 12 17:07 ET

Wan Bond: Report for the third quarter of 2024

SZSIOct 29 12:00 ET · Announcements

Subdued Growth No Barrier To Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE:002082) With Shares Advancing 38%

Simply Wall StOct 21 18:11 ET

Wanbangde Pharmaceutical Names CFO

MT NewswiresSep 30 04:37 ET

Wanbangde Pharmaceutical Holding Group: The financial director, who served for only eight months, resigned, and the chairman once again acted as the director. | Quick Read Announcement

①Tonight, wanbangde pharmaceutical holding group announced that the Chief Financial Officer Wang Tianfang has resigned, having served in this position for only 8 months; ②Chairman Zhao Shouming once again assumes the responsibilities of the Chief Financial Officer, having temporarily served in this role when the former CFO Zhao Junhui resigned in June 2022; ③Within three years, wanbangde pharmaceutical holding group's market cap has shrunk to only one-third.

cls.cnSep 29 11:29 ET

Concerns Surrounding Wanbangde Pharmaceutical Holding Group's (SZSE:002082) Performance

Simply Wall StSep 4 18:20 ET